Algo version: 0.98b
Sipai Health Technology is listed at the HKSE Exchange
Sipai Health Technology [0314.HK]
HKSE Sector: Healthcare Industry:Healthcare

Is Sipai Health Technology stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Sipai Health Technology 10 years ago, but if you had invested on Friday 23rd of December 2022 when the price was HKD25.00, you would have made a loss of HKD-19.33 per share or -77.32%

Yes, the average daily trading liquidity for Sipai Health Technology is HKD918 237 thousand. You should therefore be able to get in and out of your positions relatively fast.

Sipai Health Technology has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Sipai Health Technology to be low [0 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.